Form 4 for BDTX Black Diamond Therapeutics, Inc.
Accepted 2025-09-22 00:00:00 ET · period of report 2025-09-19 · accession 0002018686-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-22 | 2025-09-19 | BDTX | Raman Prakash | Dir | A - Grant | $3.35 | +3,843 | 26.4K | +17% | +$12.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-19 | A | A | 3,843 | $3.35 | 26,362 | D | — | — | (F2) The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on September 18, 2025. |